ONCO
ONCO
NASDAQ · Biotechnology

Onconetix Inc

$0.88
-0.01 (-1.03%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +313.6% upside
Low Target $2.40
Average Target $3.65
High Target $4.80
Current Price $0.88
Current
$0.88
Target
$3.65
$2.40 $3.65 avg $4.80
Scenario Analysis
Bear Case
$2.40
172.0%
Low target
Base Case
$3.65
+313.6%
Avg target
Bull Case
$4.80
+444.0%
High target
Risk/Reward
2.6x
Favorable
Price in Context
Target vs 52W High
$3.65
-98.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +2.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -15.1%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.5%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.6%